TABLE 1 Clinical applications of induced hypothermia in intensive care medicine Neurosurgery
Induced hypothermia (IH) has been used for over fifty years as adjunctive therapy in a wide range of critical illnesses (Table 1) . Following the first report of the use of IH in humans in 1939 1 , there was considerable interest and research, particularly during the 1950s. Since then, IH (with cardiopulmonary bypass) has been used extensively for cerebral protection during cardiac and neurological surgery 2 , but until recently, there has been little interest in the application of IH, without cardiopulmonary bypass, in the intensive care unit (ICU).
In fact, hypothermia (occurring accidentally) in critically ill patients has come to be regarded as hazardous, particularly in patients with trauma 3, 4 , sepsis syndrome 5, 6 or following major surgery 7, 8 . Recent prospective, randomized, controlled human trials have, however, suggested benefit of IH, applied in the ICU, in traumatic brain injury [9] [10] [11] and the adult respiratory distress syndrome (ARDS) 12 . Also, further investigation of IH in patients with anoxic brain injury has been proposed 13, 14 following promising results in animal models [15] [16] [17] [18] [19] . This paper reviews the past and current areas of clinical research into IH and also some of the physiological changes that may be seen.
THE HISTORY OF INDUCED HYPOTHERMIA
The pioneer of IH in clinical medicine was Dr Temple Fay, at Temple University, Pennsylvania, U.S.A.. In 1939, after observing that hypothermia caused the regression of malignant tumours in vitro 20 , he induced hypothermia (to 32°C) using surface cooling and sedation in a young woman with metastatic carcinoma of the breast. The goal was to relieve pain and to slow further spread of the tumour. IH was maintained for 24 hours, following which the patient was rewarmed without apparent ill effect 1 . Subsequently, he used IH, for periods of up to eight days, in a series of 124 patients suffering intractable pain from metastatic carcinoma. The mortality rate during or immediately after IH in these "terminally-ill" patients was reported as 11%. The technique was thought to be well tolerated, although no claims were made as to efficacy 21 .
In 1941, Fay used IH in a patient with severe head injury. He noted marked clinical improvement at a decreased body temperature and IH was maintained for several days. Following this satisfactory outcome, Fay cooled many further patients with severe head injury, with results that appeared promising 22 . In all these patients, hypothermia was induced using surface cooling and oral sedation (to suppress shivering) and was undertaken in general wards, without assisted ventilation or electrocardiographic monitoring, for periods of hours to days.
During the 1940s, however, the infamous experimental use of IH on patients without consent or anaesthesia at Dachau discouraged further experimentation or application of IH for some years 22 . In 1950, Bigelow introduced hypothermia as a means of cerebral protection during cardiac surgery 23 . This initiated a resurgence of research into IH for a wide variety of clinical conditions during the 1950s, summarized in 1959 in an extensive review by Vandam and Burnap 24 .
Despite this enthusiasm for IH in the 1950s, reports of the use of IH declined dramatically after 1960. The reasons for this are unclear, but may relate to the development of alternative therapies which were thought to be more effective. At this time, controlled mechanical ventilation and improved monitoring in ICUs were becoming available. In addition, notwithstanding the theoretical benefits of organ protection afforded by hypothermia and promising anecdotal reports, there were concerns regarding possible complications, including dysrhythmias, coagulopathy and pulmonary infection [25] [26] [27] .
CURRENT INTERESTS
At present, the main research interest in IH is in patients with traumatic brain injury, anoxic brain injury and adult respiratory distress sydnrome.
Traumatic Brain Injury
In patients who have suffered a severe neurological insult, therapy is directed towards maintaining an adequate supply of oxygen to meet cerebral metabolic oxygen demand, thus avoiding a "secondary" injury 28 . Following severe head injury, it is thought that some areas of the brain are hyperperfused and others hypoperfused, because of the loss of autoregulation 29 . There may be focal or generalized cerebral ischaemia for some days after severe traumatic brain injury 30 .
Moderate hypothermia is theoretically attractive in this setting, as there is a 7% decrease in the cerebral metabolic rate for oxygen for each degree Celsius decrease in temperature without a corresponding decrease in cerebral oxygen supply 31 . In addition, moderate hypothermia lowers intracranial pressure [9] [10] [11] 32, 33 and may act as an anticonvulsant 34 .
Despite these theoretical benefits, promising animal studies 35, 36 and many anecdotal clinical reports 22, 32, [37] [38] [39] [40] [41] [42] [43] [44] , it is only recently that prospective, randomized, controlled trials of IH in humans with traumatic brain injury have been published [9] [10] [11] .
Marion et al compared twenty patients with severe traumatic brain injury who underwent moderate IH (32-33°C for 24 hours) with twenty patients maintained at normothermia 9 . Patients with IH had significantly reduced intracranial pressure (by 40%) and there was a favourable effect on cerebral oxygen demand and supply. There were no differences in systemic complications. In this small study, outcome at three months was not significantly different, although there was a trend toward better outcome in the IH group, with 12/20 patients having moderate, mild or no disability at three months vs 8/20 in the control group.
Shiozaki et al used IH in patients with severe traumatic brain injury who had uncontrolled intracranial hypertension despite barbiturate therapy 10 . Sixteen patients were randomized to moderate IH (34°C for 48 hours) with 17 similar patients acting as controls. In the patients undergoing IH, the intracranial pressure decreased by a mean of 10.4 mmHg and cerebral perfusion pressure increased by a mean of 14.0 mmHg. In the normothermic group, 12 of 17 patients showed progressive elevation of intracranial pressure despite conventional reduction therapies. Eight patients (50%) in the IH group and three (18%) in the control group survived (P<0.05), while five (31%) in the hypothermia group and 12 (71%) in the control group died of uncontrollable intracranial hypertension (P<0.05).
In a third study, Clifton et al randomized 22 patients with severe traumatic brain injury to standard therapy, including normothermia, and 24 patients to similar therapy but including IH (32-33°C for 48 hours) 11 . There were no significant differences between the two groups at entry: however, there was a trend towards improved outcome, with a 16% increase in patients with good outcome in the hypothermic group at three months, although this was not significant (P>0.287). It was calculated that several hundred patients would need to be enrolled for this trend to become statistically significant.
There are concerns about possible detrimental effects of hypothermia in trauma patients, with evidence suggesting that (accidental) hypothermia occurring during resuscitation may increase mortality. For example, Jurkovich et al reviewed the temperatures of 71 patients following major truncal trauma who underwent emergency thoracotomy and/or laparotomy and found that nine patients had a core temperature less than 32°C in the operating room 3 . The postoperative mortality in this sub-group was 100%. Mortality was also associated with a higher injury severity score and increased blood transfusion. In another study, Luna et al prospectively studied 94 intubated injured patients at a trauma centre during a 16-month period 4 . A temperature of less than 34°C was noted in 22/94 and the mortality rate was 59% in this group compared with 22% in normothermic patients (P<0.05).
Neither of these studies discussed the causes of death; thus the mechanism by which hypothermia increased mortality in these studies is uncertain. It is possible that hypothermia increased traumatic blood loss, since there have been reports of an association between hypothermia, trauma and abnormal bleeding 45 . It is known that hypothermia prolongs prothrombin and partial thromboplastin times 46 and hypothermia also has an adverse effect on platelet function 47 . Each degree Celsius decrease in temperature is associated with a 15% decrease in thromboxane B2, which constricts blood vessels and aggregates platelets at bleeding sites 48 .
The clinical significance of this alteration in coagulation in patients with traumatic brain injury is uncertain. There were no reports of bleeding complications in the three controlled trials of IH in patients with severe traumatic brain injury [9] [10] [11] . In one study which specifically examined clotting profiles in hypothermic patients and normothermic control patients, no significant differences were found 49 .
There are also concerns that hypothermia may lead to lactic acidosis 50 . However, there were no significant differences in the lactate levels of normothermic and IH patients with traumatic brain injury 51 . Another report on the same patients also showed that there were no additional pulmonary complications 52 .
A literature review, including animal studies, human studies, technique and complications of IH following traumatic brain injury has recently been published 53 .
Anoxic Brain Injury
Cardiac arrest occurring out-of-hospital is common and associated with a low survival rate 54 . Many patients remain comatose due to the anoxic cerebral injury 55 .
There is evidence that a substantial component of this neurologic injury occurs after return of spontaneous circulation due to the "reperfusion injury" 14, 56 . This is thought to be multi-factorial and includes complex biochemical cascades that lead to neuronal necrosis via lipid peroxidation, mediated by oxygen-free radicals, calcium, superoxide dismutase and glutamate 14, 56, 57 . In addition, global cerebral hypoperfusion may be accompanied by normal or supranormal cerebral oxygen demand for up to twelve hours post-arrest 14, 58 . Other contributing, potentially adverse factors include inflammatory processes 14 and cerebral oedema 59 .
There has been extensive research into therapeutic strategies which might be implemented in the early post-arrest period, following return of spontaneous circulation 60 . Prospective, randomized, controlled human trials have investigated the use of thiopentone 61 , corticosteroids 62 and a calcium antagonist, lidoflazine 63 . None of these agents showed benefit. Currently, research in animal models is focusing on IH 14, 15, 60, 64 , other calcium antagonists (ie. levemopamil) 65 , hypertensive reperfusion 14 , as well as "multifaceted therapy", which combines hypothermia, hypertension, thiopentone, phenytoin, steroids, haemodilution and normocapnia 18 .
It is known that hypothermia induced prior to, or during, cardiac arrest has a protective effect on the brain, with seemingly "miraculous" recoveries after ice-water near-drownings 66, 67 and burial under snow 68 , but there are few reports of the use in humans of IH after return of spontaneous circulation following cardiac arrest. The only published experience in adults is from Benson et al, who in 1958 reported good outcomes when IH was applied in four patients who were resuscitated from cardiac arrest 69 . The following year, the same group treated twelve patients who underwent thoracotomy for cardiac arrest with moderate hypothermia induced after return of spontaneous circulation and maintained for up to eight days 70 . In this group, there were six survivors (50%), compared with only one survivor in seven case controls. Despite this promising report, there have been no further publications describing the use of IH in adults with anoxic brain injury.
Bohn et al evaluated the use of IH (with hyperventilation and high-dose barbiturate therapy) in 24 children with anoxic brain injury following near drowning, between 1978 and 1980 71 . These patients were compared with 16 patients treated over three subsequent years with a protocol that was similar, except that patients were maintained at normothermia. The authors noted that the IH group had a higher incidence of neutropenia and septicaemia. They also concluded that IH did not improve neurological outcome.
Over recent years, there has been renewed interest in the application of IH after return of spontaneous circulation in anoxic brain injury. In an animal model of anoxic brain injury, dogs underwent ten minutes of cardiac arrest (ventricular fibrillation) which was induced by an F.A.C.E.M., shock, followed by five minutes of mechanical ventilation and external cardiac massage 16 . Return of spontaneous circulation was achieved by DC countershocks. Immediately thereafter, moderate hypothermia (34°C) was induced by surface cooling and maintained for 60 minutes. Evaluation at 72 hours showed significant improvement in outcome in the IH group, compared with normothermic controls.
Further work from the same group looked at the effect of immediate versus delayed IH (15 minutes following return of spontaneous circulation) in this model and found that the latter group of animals had slightly decreased cerebral tissue damage on cerebral microscopy but no improvement in functional outcome over controls 19 . Another study in a rat model of focal cerebral ischaemia following middle cerebral artery occlusion suggested that mild hypothermia is beneficial even when induced up to one hour following the onset of ischaemia 72 . It has also been shown that, whilst mild hypothermia has a beneficial effect in dogs in this setting, deep post-arrest hypothermia (15°C) (using cardiopulmonary bypass) may worsen cerebral and cardiac outcome 17 .
However, there are concerns that IH may cause an increase in complications in patients who may be haemodynamically unstable following resuscitation from cardiac arrest, since many of these patients have myocardial ischaemia 55 . As core temperature decreases, cardiac output falls by approximately 5% for each degree Celsius fall in core temperature, mainly as a consequence of a decreased heart rate. Interestingly, this bradycardiac effect has been used for the treatment of tachyarrhythmias refractory to drug therapy in children 73 . Junctional bradycardia and atrial fibrillation with a slow ventricular response rate may be seen when the temperature drops to 30°C. Stroke volume is largely maintained, as is myocardial contractility. Because of an increase in systemic vascular resistance 26, 74 , blood pressure is little affected. There may be electrocardiographic changes, with the characteristic appearance of a notch on the QRS complex (the J wave or Osbourne wave) 75 .
Major cardiac arrhythmias should only occur when the core temperature drops below 30°C 76 . There is considerable risk of ventricular fibrillation at 28°C or lower, especially in the presence of hypokalaemia, which commonly occurs as core temperature decreases 77 . Hypothermia results in the movement of potassium into cells 78, 79 . Koht reported a mean serum potassium of 2.3 5 0.4 mEq/l in a series of six patients who underwent IH for brain injuries. Caution with potassium supplementation was advised, since rebound hyperkalaemia was noted to occur 80 .
Recent reviews of anoxic brain injury have suggested that IH is a promising strategy for cerebral post-arrest resuscitation 14, 60, 64 . Since it is likely that IH will have maximum cerebral benefit when applied immediately after return of spontaneous circulation, clinical methods for the rapid induction of mild to moderate hypothermia in comatose survivors of cardiac arrest will need to be developed to assess this therapy 14, 81, 82 .
Adult Respiratory Distress Syndrome
At present, patients with severe ARDS are managed with supportive care, including mechanical ventilation and, if possible, treatment of the underlying condition. Mortality and morbidity remain high, mainly due to multi-organ system failure and sepsis 83 . Pulmonary barotrauma may occur, especially when high levels of positive end expiratory pressure are required to maintain satisfactory oxygen delivery 84 . In ARDS, IH has the theoretical benefit of decreasing lung injury by decreasing oxygen consumption and carbon dioxide production 85 , allowing alterations of the ventricular settings in order to minimize barotrauma. In addition, it has been proposed that prolonged tissue ischaemia is a factor in the development of multi-system organ failure in sepsis and that IH may improve the ratio between tissue oxygen supply and demand 86 .
The first published use of IH in the management of severe respiratory failure was in 1983 when Gilston induced hypothermia (to 34°C) for three days in a 16-month-old child suffering severe pulmonary oedema 87 . A marked improvement in the P a O2 at the lower temperature was noted and the child recovered. The use of IH in respiratory failure in an adult was reported by Hurst et al in 1985 88 . In addition to steep Trendelenberg position and highfrequency jet ventilation, he cooled a 32-year-old female with severe ARDS to 33°C for ten days. Complications of mild metabolic acidosis and decreasing white cell and platelet counts were noted, but the patient eventually recovered. In another case report, Wetterberg and Steen used IH (to 33.3°C) for 11 days in a 20-year-old male with post-traumatic ARDS, with eventual full recovery and no particular complications 89 .
Recently, the results of a small, prospective, controlled trial using IH in patients with severe ARDS were published 12 . Villar et al treated a series of nineteen patients suffering severe respiratory failure (due to sepsis). The authors claim that the study patients had a predicted mortality rate of 100%, based on P(A-a)O2 > 500 Torr for more than 36 hours. Nine patients were randomized to undergo IH (33.7 ±0.6°C) and ten remained normothermic, in addi-
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Anaesthesia and Intensive Care, Vol. 24, No. 3, June 1996 tion to standard therapy. This study noted decreases in alveolar-arterial oxygen gradient, intrapulmonary shunt, heart rate and cardiac index but, interestingly, no decrease in oxygen consumption. The mortality rate was 100% in a group of nine historical controls, 100% in the ten patients randomized to normothermia and 66% (6/9 patients) in the IH group (P<0.05).
However, many deaths from ARDS are caused by uncontrolled sepsis and there is concern that hypothermia may be associated with an increase in mortality in this setting 6 . For example, Clemmer et al randomized 382 patients with sepsis syndrome to treatment with methylprednisolone or placebo 5 . There were 34 (9%) patients who were hypothermic (<35°C) on entrance. These patients had a significantly higher incidence of circulatory shock, central nervous system dysfunction, coagulopathy and death than normothermic patients.
It has been suggested that hypothermia may have an adverse effect on the immune system by reducing the release of neutrophils from the marrow to the circulation 90 . This was thought to be a contributory factor to the high rate of septicaemia in children undergoing IH for anoxic brain injury 71 . On the other hand, other studies have indicated a beneficial effect of hypothermia in sepsis 91, 92 .
Other Applications of IH
There have been anecdotal reports of the use of IH in critically ill patients with a variety of conditions other than those discussed above and these are shown in Table 1 .
SUMMARY
Induced hypothermia as adjunctive therapy has been the subject of considerable research interest and debate for over fifty years. Recently the first prospective randomized controlled trials were undertaken in humans with severe traumatic brain injury, with supportive results. Another prospective controlled study of induced hypothermia in severe septic adult respiratory distress syndrome also suggested improved outcome. Other studies in patients with anoxic brain injury have been suggested following promising findings in animal models. There have been anecdotal reports of the use of induced hypothermia in a wide range of other neurological injuries.
There are significant physiological changes during induced hypothermia, particularly affecting the cardiovascular system. In addition, hypokalaemia, prolonged clotting times and neutropenia may occur. The evidence that induced hypothermia may be hazardous is mostly drawn from the literature on accidental hypothermia occurring in trauma, or patients with sepsis.
It is likely that further trials will be conducted and if benefit is confirmed, induced hypothermia may become more widely used in selected patients in the intensive care unit.
